Open Date

07 Nov 2023

09 Nov 2023


₹10.85 Cr

Lot Size

IPO Size

Listing At


Listing  Date

Price Range

₹84 per share

Close Date

Allotment Date

15 Nov 2023

20 Nov 2023

IPO Details

Sunrest Lifescience Limited, founded in 2017, provides a wide range of healthcare and personal care goods. Sunrest Lifescience's product portfolio includes anti-bacterial, anti-diarrheal, anti-fungal, anti-malerial, anti-diabetic, anti-diabetic, dental cure, anti-protozol, anti-histamine, anti-hypertensive drugs, cosmetic, anti-parasitic, multivitamin, multimineral, nutraceutical, and anti-inflammatory drugs. Capsules, Tablets, Syrup, Ointment, Gel, mouthwash, Solution, Suspension, Dry Powders, and Toothpaste are among the products available from the firm.

About the Company

The Issue Proceeds from the Fresh Issue will be utilized towards the following objects: 1. Meeting Working Capital Requirements 2. General Corporate Purpose 3. Meeting Public Issue Expenses


The book-running lead managers to the offer are: Mark Corporate Advisors Private Ltd

Book Runners

Disclaimer Investment/Trading in securities Market is subject to market risk, past performance is not a guarantee of future performance. The risk of loss in trading and investment in Securities markets including Equites and Derivatives can be substantial.